Envoy Medical (COCHW) Shares Outstanding (Weighted Average) (2020 - 2026)

Envoy Medical's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $68.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 223.23% year-over-year to $68.9 million; the TTM figure through Mar 2026 stood at $68.9 million (up 223.23% YoY), while the FY2025 annual figure was $2.1 million, down 88.96% from the prior year.
• Shares Outstanding (Weighted Average) came in at $68.9 million for Q1 2026 at Envoy Medical, up from $2.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $68.9 million in Q1 2026 to a low of $664883.0 in Q4 2024.
• A 5-year average of $21.3 million and a median of $18.6 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) soared 304.76% in 2022 and sank 94.59% in 2024, its largest moves.
• Envoy Medical's Shares Outstanding (Weighted Average) stood at $10.1 million in 2022, then climbed by 21.46% to $12.3 million in 2023, then tumbled by 94.59% to $664883.0 in 2024, then surged by 211.94% to $2.1 million in 2025, then surged by 3223.75% to $68.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $68.9 million, $2.1 million, and $21.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison